Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19

Retrieved on: 2021-01-05 18:00:00

Tags for this article:

Health

Life Sciences

Medical specialties

Monoclonal antibodies

Bamlanivimab

COVID-19 drug development

AbCellera

Eli Lilly and Company

Vaccine Research Center

National Institutes of Health

AIDS Clinical Trials Group

National Institute of Allergy and Infectious Diseases

Click the tags to see associated articles and topics

Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19. View article details on hiswai:

Excerpt

A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who ...

Article found on: www.nih.gov

View Original Article